In response to the pandemic, governments around the world have instituted policy changes intended to mitigate the impact of the coronavirus that could have long-lasting impacts. In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to DRG market access experts Steve Edgar and Judith Rubinstein about how new policies are reshaping supply chains, testing, development, approval and care delivery – and what it means for life sciences executives.

Hosted on Acast. See acast.com/privacy for more information.